Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways. / Marmolejo-Garza, Alejandro; Medeiros-Furquim, Tiago; Rao, Ramya; Eggen, Bart J.L.; Boddeke, Erik; Dolga, Amalia M.
I: Biochimica et Biophysica Acta - Molecular Cell Research, Bind 1869, Nr. 10, 119326, 2022.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways
AU - Marmolejo-Garza, Alejandro
AU - Medeiros-Furquim, Tiago
AU - Rao, Ramya
AU - Eggen, Bart J.L.
AU - Boddeke, Erik
AU - Dolga, Amalia M.
N1 - Publisher Copyright: © 2022
PY - 2022
Y1 - 2022
N2 - Alzheimers disease (AD) is the main cause of dementia and it is defined by cognitive decline coupled to extracellular deposit of amyloid-beta protein and intracellular hyperphosphorylation of tau protein. Historically, efforts to target such hallmarks have failed in numerous clinical trials. In addition to these hallmark-targeted approaches, several clinical trials focus on other AD pathological processes, such as inflammation, mitochondrial dysfunction, and oxidative stress. Mitochondria and mitochondrial-related mechanisms have become an attractive target for disease-modifying strategies, as mitochondrial dysfunction prior to clinical onset has been widely described in AD patients and AD animal models. Mitochondrial function relies on both the nuclear and mitochondrial genome. Findings from omics technologies have shed light on AD pathophysiology at different levels (e.g., epigenome, transcriptome and proteome). Most of these studies have focused on the nuclear-encoded components. The first part of this review provides an updated overview of the mechanisms that regulate mitochondrial gene expression and function. The second part of this review focuses on evidence of mitochondrial dysfunction in AD. We have focused on published findings and datasets that study AD. We analyzed published data and provide examples for mitochondrial-related pathways. These pathways are strikingly dysregulated in AD neurons and glia in sex-, cell- and disease stage-specific manners. Analysis of mitochondrial omics data highlights the involvement of mitochondria in AD, providing a rationale for further disease modeling and drug targeting.
AB - Alzheimers disease (AD) is the main cause of dementia and it is defined by cognitive decline coupled to extracellular deposit of amyloid-beta protein and intracellular hyperphosphorylation of tau protein. Historically, efforts to target such hallmarks have failed in numerous clinical trials. In addition to these hallmark-targeted approaches, several clinical trials focus on other AD pathological processes, such as inflammation, mitochondrial dysfunction, and oxidative stress. Mitochondria and mitochondrial-related mechanisms have become an attractive target for disease-modifying strategies, as mitochondrial dysfunction prior to clinical onset has been widely described in AD patients and AD animal models. Mitochondrial function relies on both the nuclear and mitochondrial genome. Findings from omics technologies have shed light on AD pathophysiology at different levels (e.g., epigenome, transcriptome and proteome). Most of these studies have focused on the nuclear-encoded components. The first part of this review provides an updated overview of the mechanisms that regulate mitochondrial gene expression and function. The second part of this review focuses on evidence of mitochondrial dysfunction in AD. We have focused on published findings and datasets that study AD. We analyzed published data and provide examples for mitochondrial-related pathways. These pathways are strikingly dysregulated in AD neurons and glia in sex-, cell- and disease stage-specific manners. Analysis of mitochondrial omics data highlights the involvement of mitochondria in AD, providing a rationale for further disease modeling and drug targeting.
KW - ATAC-seq
KW - Mitochondria
KW - Neurodegeneration
KW - Omics
KW - RNA-seq
U2 - 10.1016/j.bbamcr.2022.119326
DO - 10.1016/j.bbamcr.2022.119326
M3 - Review
C2 - 35839870
AN - SCOPUS:85134419024
VL - 1869
JO - B B A - Molecular Cell Research
JF - B B A - Molecular Cell Research
SN - 0167-4889
IS - 10
M1 - 119326
ER -
ID: 316678005